ACSD Announces Strategic Partnership with Medicalgorithmics to Enhance Cardiac Monitoring Services
ACS Diagnostics Inc. Announces Strategic Partnership with Medicalgorithmics to Enhance Cardiac Monitoring Services
ACS Diagnostics Inc., a leading U.S.-based Independent Diagnostic Testing Facility (IDTF) and device manufacturer, is excited to announce a new strategic partnership with Medicalgorithmics, a renowned Polish med-tech company. This collaboration will integrate Medicalgorithmics’ innovative DeepRhythm Platform (DRP) and DeepRhythmAI (DRAI) artificial intelligence algorithms with ACS Diagnostics’ patented multifunctional CORE 3 ECG wearable device.
This partnership marks a significant milestone for ACS Diagnostics as it expands its capabilities in remote cardiac monitoring services across the United States. By integrating the DeepRhythm Platform with the CORE 3 devices and the IDTF-receiving software, ACS Diagnostics will be able to offer a comprehensive suite of services, including traditional Holter monitoring, event monitoring, and mobile cardiac telemetry (MCT). This integration not only enhances the quality of service and reporting flexibility, but also enables ACS Diagnostics to continue qualifying for the highest reimbursement levels available in the U.S. market.
“We are thrilled to partner with Medicalgorithmics, a leader in AI-driven cardiac diagnostics,” said Chris Kane, President at ACS Diagnostics. “This collaboration will allow us to leverage cutting-edge technology to provide our patients with some of the most advanced and effective cardiac monitoring solutions available today.”
The agreement also opens new opportunities for Medicalgorithmics to offer ACS Diagnostics’ high-quality CORE 3 devices to other customers in both the U.S. and Europe, thereby broadening their market reach and enhancing their product portfolio.
ACS Diagnostics Inc. continues to be at the forefront of ambulatory cardiac monitoring and comprehensive remote ECG diagnostics. The CORE 3, a compact, multifunctional, and patented ECG recorder, is designed to support various monitoring modes in a single device, making it a versatile tool in the fight against cardiac diseases.
About ACS Diagnostics
ACS Diagnostics Inc. is a well-established ambulatory device company based in the United States, dedicated to advancing cardiac care through innovative diagnostic solutions. With a focus on patient-centered care, ACS Diagnostics provides a range of ambulatory cardiac monitoring services and remote ECG diagnostics, supported by state-of-the-art technology.
About Medicalgorithmics
Medicalgorithmics is a global leader in advanced software solutions for non-invasive cardiac diagnostics. With nearly two decades of experience in the medical technology market, the company specializes in developing proprietary artificial intelligence algorithms for ECG signal analysis and cardiac CT imaging. Medicalgorithmics is committed to revolutionizing cardiac diagnostics through breakthrough technologies and AI-driven automation.